Skip to main content
. 2016 Jul 16;25(4):247–251. doi: 10.1055/s-0036-1584880

Table 1. Patient demographics.

Gender 34 males, 25 females
Age (mean) 63
LVEF (mean) 0.60
HTN 73%
CAD 34%
DM 24%
BB 34%
PHx of CHF 8% (three diastolic, two systolic patients)
RAN dose (mean) 866 mg daily
Time in between Holters (mean) 3.10 mo
Symptoms
 Palpitations 100%
 Dizziness 65%
 Fatigue 33%

Abbreviations: BB, beta blocker; CAD, coronary artery disease; CHF, congestive heart failure; DM, type 2 diabetes; HTN, hypertension; LVEF, left ventricular ejection fraction; PHx, past history; RAN, ranolazine.